Aligning Interests with Shareholders Through Equity-Compensation Stock Options
First written in FY2018. 18 of 21 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-08-14.
110 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「(Summary of changes) Increase due to the exercise of stock acquisition rights: 307,400 shares」
The number of shares increased by 307,400 during the fiscal year under review as a result of the exercise of share-based compensation stock options and other rights. At fiscal year-end, 1,910,800 stock options remained unexercised. - 2026-06-26AdvancedShare Issuance and Disposal
「The purpose is to share the benefits and risks of share price fluctuations with shareholders and further strengthen their willingness to contribute to an increase in the share price and corporate value.」
2026年6月26日開催の取締役会で、取締役6名に対し2026年度新株予約権120個を上限として発行することを決議した。各新株予約権の付与株式数は100株、行使期間は2026年7月12日から2046年7月11日までとされている。 - FY2026-H1AdvancedAnnual report
「Date of resolution 27 June 2025 Category and number of grantees 5 directors of the Company Number of stock acquisition rights * 1,200 Class, details and number of shares underlying the stock acquisition rights * 120,000 common shares (Note 1) Exercise period for the stock acquisition rights * 13 July 2025 to 12 July 2045 (Note 3)」
As part of the executive compensation structure, the Company issued 1,200 stock acquisition rights covering 120,000 common shares to 5 directors based on the resolution dated 27 June 2025 and set the exercise period. - FY2025ReframedAnnual report
「Specifically, the compensation consists of base compensation as fixed compensation (cash compensation), performance-linked compensation (cash compensation) and share-based compensation. The approximate proportions of base compensation, performance-linked compensation and non-monetary compensation, among others, are 70%, 5% and 25%, respectively.」
The explanation was reorganized from one centred on stock options as share-based compensation to an executive compensation structure combining base compensation, performance-linked cash compensation and share-based compensation, with the respective proportions also disclosed. - FY2025-H1AdvancedAnnual report
「Stock acquisition rights issued during the interim accounting period are as follows: Date of resolution: 26 June 2024 Category and number of grantees: 5 directors of the Company Number of stock acquisition rights: 1,200 Class, details and number of shares underlying the stock acquisition rights: 120,000 common shares Exercise period: 12 July 2024 to 11 July 2044」
Based on the resolution dated 26 June 2024, the Company issued 1,200 stock acquisition rights covering 120,000 common shares to 5 directors and set the exercise period from 12 July 2024 to 11 July 2044. - FY2024-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows.」
Based on the resolution dated 28 June 2023, the Company issued 1,400 stock acquisition rights and 140,000 common shares to 6 directors, and set the exercise period from 14 July 2023 to 13 July 2043. - FY2023-Q3AdvancedAnnual report
「Company directors 5 people Number of stock acquisition rights * 1,700 Class, details and number of shares underlying the stock acquisition rights * Common shares 170,000 shares (Note) 1 Exercise period for the stock acquisition rights * 14 October 2022 to 13 October 2042 (Note) 3」
Based on the resolution of 28 September 2022, the company issued 1,700 stock acquisition rights and 170,000 common shares to 5 directors and set the exercise period. - FY2023-Q2AdvancedAnnual report
「Number of stock acquisition rights 6,780 Class, details and number of shares underlying the stock acquisition rights Common shares 678,000 shares (Note) 1 Exercise period for the stock acquisition rights 1 October 2024–30 September 2028」
Based on resolutions of the annual general meeting of shareholders and the Board of Directors dated 28 September 2022, the company granted 6,780 Series 27 stock acquisition rights and 678,000 common shares to directors, Audit & Supervisory Board members, employees, and employees of group subsidiaries. - FY2022ReframedAnnual report
「The company’s policy for determining directors’ remuneration is to establish a remuneration structure that functions sufficiently as an incentive for the sustainable enhancement of corporate value. Specifically, it comprises basic remuneration as fixed remuneration, consisting of cash remuneration, and share-based remuneration. The ratio of basic remuneration to non-monetary remuneration and other remuneration is approximately 70%:30%.」
Share-based stock options are positioned not only as a means of aligning interests with shareholders but also as part of the executive remuneration structure, including the ratio to fixed remuneration. No performance-linked remuneration is used. - FY2022-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows.」
Based on the resolution of 28 June 2021, the company issued 1,200 stock acquisition rights and 120,000 common shares to 4 company directors. The exercise period is from 16 July 2021 to 15 July 2041. - FY2022-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period were as follows.」
Based on the resolution of 28 June 2021, the company issued 5,835 stock acquisition rights and 583,500 common shares to 6 directors, 3 Audit & Supervisory Board members, 9 company employees, and 151 subsidiary employees. The exercise period was set from 1 July 2023 to 30 June 2027. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows.」
Based on the resolution of 30 June 2020, the company issued 1,000 stock acquisition rights and 100,000 common shares to 4 company directors. The exercise period was set from 18 July 2020 to 17 July 2040. - FY2021-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period were as follows.」
Based on the resolution of 30 June 2020, the company issued 5,720 stock acquisition rights and 572,000 common shares to 6 directors, 3 Audit & Supervisory Board members, 8 company employees, and 161 subsidiary employees, with an exercise period from 1 July 2022 to 30 June 2026. - FY2020-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From 1 October through 31 December 2019, 1,800 shares were issued through the exercise of stock acquisition rights, and the share-based stock options continued to be exercised. - FY2020-Q2AdvancedAnnual report
「Number of stock acquisition rights * 900 Stock class, details and number of shares underlying the stock acquisition rights * Common shares 90,000 shares (Note) 1 Exercise period for the stock acquisition rights * 14 July 2019–13 July 2039 (Note) 3」
Based on the resolution of 26 June 2019, the company issued 900 stock acquisition rights and 90,000 common shares to 3 directors and set the exercise period. In addition, 10,600 shares were issued through the exercise of stock acquisition rights during the quarter. - FY2020-Q1AdvancedAnnual report
「Number of stock acquisition rights 3,920 (Note) 1 Class, details and number of shares underlying the stock acquisition rights Common shares 392,000 shares (Note) 1 Exercise period for the stock acquisition rights 1 July 2021–30 June 2025」
Based on the resolution of 26 June 2019, the company issued 3,920 stock acquisition rights and 392,000 common shares to directors, Audit & Supervisory Board members, employees, officers and employees of subsidiaries, and others. - FY2019-Q3AdvancedAnnual report
「12,000」
From October through December 2018, 12,000 shares were issued through the exercise of stock acquisition rights, documenting the exercise of the share-based stock options in practice. - FY2019-Q1AdvancedAnnual report
「Number of stock acquisition rights 4,810 (Note) 1 Class, details and number of shares underlying the stock acquisition rights Common shares 481,000 shares (Note) 1 Exercise period for the stock acquisition rights 1 July 2020–30 June 2024」
The share-based stock options approved on 27 June 2018 were issued, with specific allocations of 4,810 options and 481,000 common shares to directors, Audit & Supervisory Board members, executive officers, officers and employees of subsidiaries, and others. - FY2018First statedAnnual report
「The purpose is to share the benefits and risks of share price fluctuations with shareholders and further strengthen their willingness to contribute to an increase in the share price and corporate value.」
Share-based stock options for directors can be identified for the first time as a separate topic, positioned as a means of aligning interests with shareholders and increasing the desire to contribute to corporate value enhancement. The resolution of 27 June 2018 set a maximum of 775 options and 77,500 common shares.